Autor: |
Simon E. Koele, Thomas P. C. Dorlo, Caryn M. Upton, Rob E. Aarnoutse, Elin M. Svensson |
Jazyk: |
angličtina |
Rok vydání: |
2024 |
Předmět: |
|
Zdroj: |
CPT: Pharmacometrics & Systems Pharmacology, Vol 13, Iss 3, Pp 374-385 (2024) |
Druh dokumentu: |
article |
ISSN: |
2163-8306 |
DOI: |
10.1002/psp4.13089 |
Popis: |
Abstract Adequate power to identify an exposure‐response relationship in a phase IIa clinical trial for pulmonary tuberculosis (TB) is important for dose selection and design of follow‐up studies. Currently, it is not known what response marker provides the pharmacokinetic‐pharmacodynamic (PK‐PD) model more power to identify an exposure‐response relationship. We simulated colony‐forming units (CFU) and time‐to‐positivity (TTP) measurements for four hypothetical drugs with different activity profiles for 14 days. The power to identify exposure‐response relationships when analyzing CFU, TTP, or combined CFU + TTP data was determined at 60 total participants, or with 25 out of 60 participants in the lowest and highest dosing groups (unbalanced design). For drugs with moderate bactericidal activity, power was low ( |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|